Kate Robinson
Assistant Editor
Kate graduated from Sheffield Hallam University with a bachelor's degree in biomedical sciences in 2020. During her studies she developed a passion for science communication and after graduating, began a science blog in order to continue writing about trending science news and topics of interest. She joined the editorial team at Technology Networks in 2021. In her role as assistant editor Kate supports the publication’s in-house writers, produces scientific content across all communities and works closely with the managing editor to help coordinate commissioned pieces.
Latest Content
Industry Insight
A Novel Nasal Swab for Lung Cancer Detection
Technology Networks spoke to Dr. Giulia Kennedy, chief scientific officer and chief medical officer for Veracyte, to learn more about the Percepta Genomic Atlas and nasal swab tests for the diagnosis of lung cancer.
Industry Insight
Exploiting Natural Disease Resistance in Mammals To Advance Drug Development
We spoke to Ashley Zehnder, CEO and founder of Fauna Bio to learn more about how the company seeks to find new treatments for diseases such as cancer and Alzheimer’s, by exploiting natural disease resistance in mammals.
Article
The Ethics and Safety of COVID-19 Vaccine Passports
We spoke to Tasnime Osama, honorary clinical research fellow at Imperial College London to learn about the ethical considerations surrounding vaccine passports and how ethical hacking could improve their security.
Industry Insight
What Does the Fourth Industrial Revolution Mean for Research?
LabVantage Solutions, Inc., a provider of laboratory informatics software solutions, has signaled a turn towards the future with its appointment of digital transformation veteran Mikael Hagstroem as its new chief executive officer. We spoke to Mikael to find out more.
Industry Insight
Detecting Residual Cancer Using Whole-Genome Sequencing and Artificial Intelligence
When a tumor is surgically removed, small amounts of residual cancer can remain at a level that is undetectable with current imaging or blood-based approaches. In this interview, Technology Networks spoke with Asaf Zviran, co-founder and CEO of C2i Genomics to find out more about the company’s C2-Intelligence Platform for the detection of trace amounts of cancer.
Podcast
Opinionated Science Episode 24: Mayan Bones, Boozy Brains and Baboon Logic
In this episode, the TN team review what happens in the brain when we drink alcohol, find out how to use baboons and grapes to make discoveries about logic processing and unearth the rise-and-fall life story of an ancient Mayan.
Industry Insight
The Development of Natural Killer Cells for Solid Tumor Treatment
We interviewed Jan Davidson MD., PhD., the newly appointed chief medical officer at Wugen to learn more about the company's agreement with Washington University to further their Memory NK Cell program.
Industry Insight
Accelerating Scientific Study With Scalable Single-Cell Sequencing
Technology Networks recently interviewed Alex Rosenberg, co-founder and CEO of Parse Biosciences to learn more about the company and its novel approach to single-cell sequencing.
Article
Targeting the Dopamine Receptor Pathway To Treat AML
Technology Networks recently interviewed Prof. Mick Bhatia, from McMaster University, to learn more about his research focused on the role of abnormal dopamine receptor pathway activation in adult patients with acute myeloid leukemia (AML).
Advertisement
